Receptor Tyrosine Kinases in Neurodegenerative and Psychiatric Disorders - Image 1

£105.16

Academic Press Receptor Tyrosine Kinases in Neurodegenerative and Psychiatric Disorders

Name: Receptor Tyrosine Kinases in Neurodegenerative and Psychiatric Disorders
Brand: Academic Press
Price: 105.16 GBP
Availability: InStock

Illnesses & Conditions

It has never been this cheap. We have no record of a lower price.

£105 today · cheaper than every other day in the last 4 months

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↓ Price chart
when this has been cheap or pricey

↓ Forecast
where the price is heading next

↓ Statistics
all-time high & low, recent range

↑ Price alert
name your number, we'll email you

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 24 days • 24 data points (No recent data available)

Historical

Generating forecast...

Price Distribution

Price distribution over 24 days • 2 price levels

Days at Price

Current Price

Price Analysis

Most common price: £105 (23 days, 95.8%)

Price range: £105 - £106

Price levels: 2 different prices over 24 days

Description

Overexpression of receptor tyrosine kinases (RTKs) has been implicated in cancer. Increasing evidence suggests that dysregulation of RTKs is reported in many neurodegenerative and psychiatric disorders. Receptor Tyrosine Kinases in Neurodegenerative and Psychiatric Disorders provides a fundamental, pragmatic map of RTKs structure, activation, functions, mechanism of action, gene regulation, and signaling pathways in developing central nervous system (CNS), adult normal CNS, neurodegenerative and psychiatric disorders. Additionally, the structure, function, activation, and therapeutic potential of many growth factors have been covered. Here, international experts in the field offer a comprehensive discussion of results of pre-clinical and clinical studies of repositioning of anti-cancer receptor tyrosine kinase inhibitors (RTKIs) and other promising protein kinase inhibitors in various neurodegenerative disorders including, Alzheimer’s disease, Parkinson’s disease, amyotrophic lateral sclerosis, Huntington's disease, and multiple sclerosis, and psychiatric disorders including, anxiety, depression, alcohol use disorder, and schizophrenia. In addition, the book discusses the obstacles and opportunities for the potential repositioning of kinase inhibitors in neurodegenerative and psychiatric disorders. Provides a thorough overview of RTKs biology and their role in health and disease progression and modulation Highlights RTK families and the numerous receptors within each subfamily Examines RTKIs and other protein kinase inhibitors in pre-clinical and clinical trials in both neurodegenerative and psychiatric disorders Gives future directions of possible safe effective targeted RTKIs and other protein kinase inhibitors that may be repositioned in various neurodegenerative and psychiatric disorders Includes chapter contributions from renowned experts in biology, pharmacology, neurology, psychiatry, and oncology

Key Features

New Store Stock

Product Specifications

Brand: Academic Press
Format: paperback
ASIN: 0443186774
Category: Books > Subjects > Health, Family & Lifestyle > Health Issues > Illnesses & Conditions
Domain: Amazon UK
Release Date: 15 June 2023
Listed Since: 19 January 2023

Barcode

No barcode data available

Academic Press Receptor Tyrosine Kinases in Neurodegenerative and Psychiatric Disorders

It has never been this cheap. We have no record of a lower price.

Price History & Forecast

Price Distribution

Price Analysis

Description

Key Features

Product Specifications

Barcode

Similar Products You Might Like

Sigma Receptors: Their Role in Disease and as Therapeutic Targets: 964 (Advances in Experimental Medicine and Biology, 964)

Parkinson's Disease and Related Disorders, Part II (Volume 84) (Handbook of Clinical Neurology, Volume 84)

Clinical Studies and Therapies in Parkinson's Disease: Translations from Preclinical Models

Central Nervous System Diseases: Innovative Animal Models from Lab to Clinic (Contemporary Neuroscience)

Drug Discovery Approaches for the Treatment of Neurodegenerative Disorders: Alzheimer's Disease

Neurodegenerative Diseases: Pathology, Mechanisms, and Potential Therapeutic Targets: 15 (Advances in Neurobiology, 15)

Advances in Neuropharmacology: Drugs and Therapeutics

Cortico-Subcortical Dynamics in Parkinson’s Disease (Contemporary Neuroscience)

Translational Neuropsychopharmacology: 28 (Current Topics in Behavioral Neurosciences, 28)

Neurobiology of Huntington's Disease: Applications to Drug Discovery (Frontiers in Neuroscience)

Parkinson's Disease and Related Disorders Part I (Volume 83) (Handbook of Clinical Neurology, Volume 83)

Genetics, Neurology, Behavior, and Diet in Parkinson's Disease: The Neuroscience of Parkinson’s Disease, Volume 2

Springer Animal Models of Neurological Disorders Textbook

Translational Approaches to Unravelling Non-Motor Symptoms of Parkinson’s disease (Volume 174) (International Review of Neurobiology, Volume 174)

Parkinson's Disease: Molecular and Therapeutic Insights From Model Systems

Psychiatric Aspects Of Neurologic Diseases: Practical Approaches to Patient Care

Basic Neurochemistry: Principles of Molecular, Cellular, and Medical Neurobiology

Parkinson's Disease and Movement Disorders

Molecular Neuropharmacology: A Foundation for Clinical Neuroscience, Fourth Edition (INTERNAL MEDICINE)

Neurotoxic Factors in Parkinson’s Disease and Related Disorders

The Neuroscience of Parkinson's Disease

5-HT2C Receptors in the Pathophysiology of CNS Disease: 22 (The Receptors, 22)

Kaufman's Clinical Neurology for Psychiatrists (Major Problems in Neurology)

Fractured Minds: A Case-Study Approach to Clinical Neuropsychology